Clinical trial
Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving…
NCT00443963 · Medstar Health Research Institute, Other · Withdrawn
Key facts
| NCT number | NCT00443963 |
|---|---|
| Title | Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs |
| Official title | Effects of Esomeprazole Magnesium on Gastric Free Radical Production and Total Antioxidant Capacity in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs |
| Lead sponsor | Medstar Health Research Institute, Other |
| Collaborators | AstraZeneca Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dyspepsia |
| Intervention type | Drug |
| Interventions | Esomeprazole Magnesium |
| Enrollment | 0 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 7, 2007 |
| Last update posted | Aug 24, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: